Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
Open Access
- 14 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica Communications
- Vol. 8 (1), 1-16
- https://doi.org/10.1186/s40478-020-0894-0
Abstract
Parkinson's disease is a progressive neurodegenerative disorder characterised by the accumulation of misfolded alpha-synuclein in selected brain regions, including the substantia nigra pars compacta (SNpc), where marked loss of dopaminergic neurons is also observed. Yet, the relationship between misfolded alpha-synuclein and neurotoxicity currently remains unclear. As the principal route for degradation of misfolded proteins in mammalian cells, the ubiquitin-proteasome system (UPS) is critical for maintenance of cellular proteostasis. Misfolded alpha-synuclein impairs UPS function and contributes to neuronal death in vitro. Here, we examine its effects in vivo using adeno-associated viruses to co-express A53T alpha-synuclein and the ubiquitinated reporter protein Ub(G76V)-GFP in rat SNpc. We found that alpha-synuclein over-expression leads to early-onset catalytic impairment of the 26S proteasome with associated UPS dysfunction, preceding the onset of behavioural deficits and dopaminergic neurodegeneration. UPS failure in dopaminergic neurons was also associated with selective accumulation of alpha-synuclein phosphorylated at the serine 129 residue, which has previously been linked to increased neurotoxicity. Our study highlights a role for alpha-synuclein in disturbing proteostasis which may contribute to neurodegeneration in vivo.Keywords
Funding Information
- Canadian Institutes of Health Research (n/a, n/a)
This publication has 55 references indexed in Scilit:
- A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in VivoNeurotherapeutics, 2012
- Distinct RolesIn Vivofor the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-SynucleinJournal of Neuroscience, 2011
- Assessment of Proteasome Impairment and Accumulation/Aggregation of Ubiquitinated Proteins in Neuronal CulturesPublished by Springer Science and Business Media LLC ,2011
- Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-SynucleinPLOS ONE, 2011
- Phosphorylated α-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent MannerPublished by Elsevier BV ,2010
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's diseaseMolecular Neurodegeneration, 2010
- A Cellular Model To Monitor Proteasome Dysfunction by α-SynucleinBiochemistry, 2009
- Limitations of SLLVY-AMC in calpain and proteasome measurementsBiochemical and Biophysical Research Communications, 2008
- Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's diseaseNeuroscience Letters, 2002